=Hologic (HOLX) reported earnings on Wed 2 May 2018 (a/h)

Hologic reports EPS in-line, beats on revs; guides Q3 EPS & revs below consensus; guides FY18 EPS in-line, revs below consensus 

• Reports Q2 (Mar) earnings of $0.53 per share, in-line with the Capital IQ Consensus of $0.53; revenues rose 10.3% year/year to $789.3 mln vs the $781.23 mln Capital IQ Consensus.
• Co issues downside guidancefor Q3, sees EPS of $0.55-0.57 vs. $0.58 Capital IQ Consensus Estimate; sees Q3 revs of $795-810 mln vs. $832.03 mln Capital IQ Consensus Estimate.
• Co issues guidancefor FY18, sees EPS of $2.22-2.27 vs. $2.26 Capital IQ Consensus Estimate; sees FY18 revs of $3.18-3.21 bln vs. $3.25 bln Capital IQ Consensus Estimate.

"We are lowering our full-year 2018 revenueguidance due primarily to a reset of our near-term sales expectations for Cynosure," said Bob McMahon, the Company's Chief Financial Officer. "But despite the reduction of our revenue forecast, we are reiterating our non-GAAP EPS guidance for the year."